Welcome to our dedicated page for Rcm Tech SEC filings (Ticker: RCMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RCM Technologies, Inc. filings document the reporting obligations of a Nevada-incorporated operating company with common stock registered on Nasdaq under the symbol RCMT. Its Form 8-K reports cover financial results, material agreements, revolving credit and loan amendments, direct financial obligations, changes in certifying accountants, and related internal control disclosures.
The company’s proxy materials address board matters, executive compensation, equity award information, and pay-versus-performance disclosure. Periodic and notice filings provide formal records around annual reporting, late-filing notifications, consolidated financial statements, risk and control matters, and the governance framework supporting RCM Technologies’ health care, engineering, information technology, life sciences, data, and solutions services.
RCM Technologies reported relatively stable results for the thirteen weeks ended April 4, 2026, with revenue of $83.0 million versus $84.5 million a year earlier. Net income was $3.8 million, down slightly from $4.2 million, and diluted earnings per share were $0.52 compared with $0.54.
Business mix shifted meaningfully. Specialty Healthcare revenue rose to $48.1 million, while Engineering declined to $26.1 million and Life Sciences, Data and Solutions eased to $8.8 million. Gross margin improved modestly to 26.5%, but higher selling, general and administrative expenses kept operating income at $5.9 million versus $6.6 million.
Operating cash flow was $2.7 million, well below the prior period’s $16.7 million, largely due to working-capital swings in receivables and transit balances. The company continued to use its balance sheet actively, repurchasing 348,366 shares at an average price of $19.03 and increasing borrowings on its revolving credit facility to $28.8 million, with $33.3 million of additional availability.
RCM Technologies, Inc. Division President of Healthcare Services Michael Saks reported an open-market sale of 1,208 shares of Common Stock at $32.50 per share. The transaction, executed on May 4, 2026, was made under a pre-established Rule 10b5-1 trading plan. Following this sale, Saks directly holds 89,267 shares of the company’s common stock.
RCM Technologies CFO Kevin D. Miller reported an open-market sale of common stock. On May 4, 2026, he sold 19,066 shares at a weighted average price of $32.03 per share, in a nondiscretionary transaction under a Rule 10b5-1 trading plan. After the sale, he directly holds 420,000 shares of RCM Technologies common stock.
Michael Saks submitted a Form 144 notice reporting proposed and recent sales of Common Stock in RCMT. The filing lists proposed sales from Employee Stock Purchase Plans of 865 and 343 shares and two recent dispositions: 4,864 shares sold on 04/16/2026 for $145,920 and 136 shares sold on 04/15/2026 for $4,080.
The broker/dealer of record is Morgan Stanley Smith Barney LLC. The filing records the sales and gives basic transaction amounts and dates; it does not include additional narrative or conditions.
RCM Technologies, Inc. filed an amended annual report to add the Part III disclosures that were originally expected to come from its 2026 proxy statement. The amendment updates information on directors, executive officers, corporate governance, executive and director compensation, security ownership, related-party oversight and auditor fees.
The filing details performance-based stock and restricted stock unit awards under the company’s equity plans, including PSUs granted to senior executives and RSUs granted to division leadership. It also outlines severance and change-in-control protections for top executives, Board committee structures, independence determinations and the company’s codes of conduct, ethics and insider trading.
RCM Technologies, Inc. reported a change in independent auditors and disclosed previously identified material weaknesses in its internal control over financial reporting. On April 29, 2026, the company dismissed EisnerAmper LLP and engaged WithumSmith+Brown, PC as its new independent registered public accounting firm.
EisnerAmper’s report on the January 3, 2026 financial statements was unqualified, and the audit committee approved the auditor change. However, EisnerAmper had communicated material weaknesses, including ineffective entity-level and business process controls, insufficient documentation of management review controls, weaknesses in risk assessment and monitoring controls, and inadequate documentation of change management and logical access controls for timekeeping systems.
The new firm, WithumSmith+Brown, will audit the company’s January 2, 2027 financial statements and internal controls and review its 2027 quarterly results. The company states there were no disagreements with EisnerAmper on accounting principles, disclosure, or audit scope, and no other reportable events beyond the described internal control weaknesses.
RCM Technologies CFO Kevin D. Miller reported an open-market sale of 4,734 shares of Common Stock at $32.00 per share. The transaction occurred on April 27, 2026 under a nondiscretionary Rule 10b5-1 trading plan. After this sale, he directly holds 439,066 shares, so the sale represents a small portion of his position.
RCM Technologies, Inc. Chief Financial Officer Kevin D. Miller reported two open-market sales of company common stock under a nondiscretionary Rule 10b5-1 trading plan. He sold 1,483 shares at $32.00 on April 22, 2026 and 2,932 shares at $32.04 on April 24, 2026.
Across both transactions, Miller sold a total of 4,415 shares and continues to hold 443,800 shares of RCM Technologies common stock directly after these sales.
RCM Technologies CFO Kevin D. Miller reported two open-market sales of common stock under a pre-arranged Rule 10b5-1 trading plan. He sold 3,000 shares at $32.00 on April 17, 2026 and 2,385 shares at a weighted-average price of $32.02 on April 20, 2026. After these transactions, he directly holds 448,215 shares of RCM Technologies common stock.
RCMT filed a Form 144 proposing the sale of 75,000 shares of Common Stock. The form lists $2,400,000.00 and a figure of 7,024,377 alongside a date of 04/17/2026 and Baird as broker. Sale methods listed include Open Market, ESPP, Salary Exchange, and RSU Vesting.